Diagnostic accuracy of cytokeratin-19 fragment (CYFRA 21–1) for bladder cancer: a systematic review and meta-analysis

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies

(2013) Penny F. Whiting   ANNALS OF INTERNAL MEDICINE

Recent advances in the diagnosis and treatment of bladder cancer

(2013) Grace Cheung et al.   BMC Medicine

Diagnostic values of urine CYFRA21-1, NMP22, UBC, and FDP for the detection of bladder cancer

(2012) Seri Jeong et al.   CLINICA CHIMICA ACTA

Systematic Reviews of Studies Quantifying the Accuracy of Diagnostic Tests and Markers

(2012) J. B. Reitsma et al.   CLINICAL CHEMISTRY

Epidemiology and Risk Factors of Urothelial Bladder Cancer

(2012) Maximilian Burger et al.   EUROPEAN UROLOGY

Meta-analyses of diagnostic studies

(2009) Ton J. Cleophas et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

The Use of Cytokeratin 19 (CK19) Immunohistochemistry in Lesions of the Pancreas, Gastrointestinal Tract, and Liver

(2009) Richa Jain et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Bias in Sensitivity and Specificity Caused by Data-Driven Selection of Optimal Cutoff Values: Mechanisms, Magnitude, and Solutions

(2008) M. M.G. Leeflang et al.   CLINICAL CHEMISTRY

Evaluation of Urine Tumor-Associated Trypsin Inhibitor, CYFRA 21-1, and Urinary Bladder Cancer Antigen for Detection of High-Grade Bladder Carcinoma

(2008) Ioannis Gkialas et al.   UROLOGY